ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.

EMBO J · 2021 · PMC7849294 · PMID 33411331

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Investigation of two separate cohorts showed a trend of increased expression of SRF that correlated with poor prognosis in NB (Fig EV3 ); however, this does not take into account modulation of SRF activity at the post‐transcriptional level.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.